Indication CINRYZE® (C1 esterase inhibitor [human]) is indicated for routine prophylaxis against angioedema attacks in adults, adolescents and pediatric patients (6 years of age and older) with Hereditary Angioedema (HAE).
When your patient is prescribed a Takeda treatment, Takeda Patient Support will be ready to help them get the answers, resources, and tools they need.
1. Complete and fax the following to 1‑866‑888‑0660:
Takeda Patient Support Start Form: in order for Takeda Patient Support to provide services to your patient, the patient will need to sign the Takeda Patient Support Start Form, which provides their consent for services. Download the English version now
A copy of your patient's insurance card(s)
2. Next a support specialist will facilitate a benefits investigation.
If your patient does not have insurance coverage, a support specialist will work with your patient to provide information about their options.
3. The support specialist will forward the prescription to a specialty pharmacy that will dispense CINRYZE.
Note that insurance companies sometimes require additional documentation to authorize coverage for CINRYZE, which could include a Statement of Medical Necessity.
Our support specialists are never more than a tap or a call away—1-866-888-0660, Monday through Friday, 8:30 AM to 8 PM ET.